Cerence Inc
NASDAQ:CRNC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cerence Inc
NASDAQ:CRNC
|
US |
|
Steven Madden Ltd
F:SJM
|
US |
|
A
|
Arcticzymes Technologies ASA
SWB:B4V
|
NO |
|
M
|
Myriad Genetics Inc
XBER:MYD
|
US |
|
Figs Inc
NYSE:FIGS
|
US |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
SA |
|
Natwest Group PLC
F:RYSD
|
UK |
|
De' Longhi SpA
F:DLN
|
IT |
Wall St Price Targets
CRNC Price Targets Summary
Cerence Inc
According to Wall Street analysts, the average 1-year price target for CRNC is 10.97 USD with a low forecast of 9.09 USD and a high forecast of 12.6 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CRNC's stock price target?
Price Target
10.97
USD
According to Wall Street analysts, the average 1-year price target for CRNC is 10.97 USD with a low forecast of 9.09 USD and a high forecast of 12.6 USD.
What is the Revenue forecast for Cerence Inc?
Projected CAGR
7%
Over the last 8 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Cerence Inc?
Projected CAGR
12%
Over the last 8 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Cerence Inc?
Projected CAGR
43%
Over the last 8 years, the compound annual growth rate for Operating Income has been -18%. The projected CAGR for the next 3 years is 43%.
